Eastman Chemical Company (EMN) reported second-quarter 2026 sales of $2.513 billion, up 10% from $2.287 billion a year earlier. Net earnings attributable to Eastman were $183 million, compared with $140 million in the prior-year quarter.
Diluted earnings per share were $1.59, up from $1.20 a year earlier. The company said sales revenue increased primarily due to 5% higher sales volume and mix and 4% higher selling prices.
- Second-quarter sales were $2.513 billion, compared with $2.287 billion in second-quarter 2025.
- Net earnings attributable to Eastman were $183 million, compared with $140 million a year earlier.
- Diluted EPS was $1.59, compared with $1.20 in the prior-year quarter.
- EBIT was $311 million, compared with $222 million a year earlier.
- Operating cash flow was $224 million, compared with $233 million in second-quarter 2025.
- By segment, Chemical Intermediates sales rose 39%, Advanced Materials sales rose 5%, Additives & Functional Products sales rose 5%, and Fibers sales fell 11%.
- Outlook includes expected 2026 operating cash flow approaching $900 million and capital expenditures of approximately $400 million.
$EMN Hedge Fund Activity
We have seen 273 institutional investors add shares of $EMN stock to their portfolio, and 288 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 2,788,735 shares (+20.4%) to their portfolio in Q1 2026, for an estimated $212,836,255
- CITADEL ADVISORS LLC removed 1,091,337 shares (-81.9%) from their portfolio in Q1 2026, for an estimated $83,290,839
- BOSTON PARTNERS added 1,076,793 shares (+inf%) to their portfolio in Q1 2026, for an estimated $82,180,841
- CAPITAL RESEARCH GLOBAL INVESTORS added 988,578 shares (+25.6%) to their portfolio in Q1 2026, for an estimated $75,448,272
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC added 732,693 shares (+39.4%) to their portfolio in Q1 2026, for an estimated $55,919,129
- HIGHTOWER ADVISORS, LLC removed 695,362 shares (-41.0%) from their portfolio in Q1 2026, for an estimated $53,070,027
- QUBE RESEARCH & TECHNOLOGIES LTD removed 671,581 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $51,255,061
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
